Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The investigational drug ipragliflozin improved glycemic control and decreased body weight and blood pressure, according to the phase III BRIGHTEN study.…
Read More »Diabetes In Control
EASD: Biomarkers May Predict CAD, Death in Diabetes Patients
Two biomarkers may be associated with cardiovascular events and death in type 2 diabetes patients, researchers reported at EASD.…
Read More »EASD: No Microvascular Benefit with Intense BP, Glucose Control
Aggressively lowering blood pressure and blood glucose together won’t provide any microvascular benefits to type 2 diabetes patients, researchers said….
Read More »Post Prandial Elevations Linked to Alzheimer’s Risk
Dementia risk may rise when glucose gets out of control, particularly after meals, according to a longitudinal study.…
Read More »Miglitol Increases GLP-1 Levels for Patients Treated with Sitagliptin
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin….
Read More »Editor’s Note: Insulin Vial Discard Dates, Polypharmacy Problems and GLP-1 Slides
Many times I get a call from a colleague asking about discarding insulin. Typically the one they ask about is Glargine. As most of you know the vial advises patients to discard the vial and remaining insulin 28 days after opening; however, due to the cost, many of our patients …
Read More »Editor’s Note: Medications’ Long-term Effects of Short-term Use
When a patient goes into the hospital they often are put on medications that affect their glucose. These meds can then follow them home where there are no clinical pharmacists or registered nurses to make sure everything runs right. This week our Case Study focuses on the use of steroids …
Read More »Managing Clinical Problems in Diabetes, Case Study #22: Combining Steroids and Insulin
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mr. WWB was referred to the diabetes educator by a nurse working on a medical ward. “We have a man here on the medical ward with COAD (chronic obstructive airways disease). …
Read More »Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5
This week we continue with Part 4 of our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents. Slides this week cover Exenatide, a synthetic version of Exendin-4 which is found in the saliva of the Gila monster….
Read More »Letter from the Editor: Prescription Drug Approval and Public Perception
As we grapple with the burgeoning diabetes problem we often have a less than favorable opinion as medical professionals of seemingly endless tests that the FDA requires for new drug and device approvals. Now a new study by Lisa M. Schwartz, MD, MS, and Steven Woloshin, MD, MS, published in …
Read More »